Elucidata
High-Quality Biological Data Systems for Drug Discovery
India · $16.0M raised
- Business Model
- B2B SaaS
- Website
- elucidata.io
- Total Funding
- $16.0M
- Last Round
- $16.0M Series ASep 2022
- Rounds
- 1
About
TechBio company powering life science R&D with ML-Ops platform Polly for drug discovery and biomedical data integration.
Summary
Elucidata is an Artificial Intelligence company based in India. It has raised $16.0M in total across 1 round, most recently a $16.0M Series A round in Sep 2022. Investors include Eight Roads Ventures, F-Prime Capital and IvyCap Ventures.
Tech & App Stack
5 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2022
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...